Comments on: First Patient Dosed with Gene Therapy in Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease

Comments on: First Patient Dosed with Gene Therapy in Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease https://www.rhiapharmaceutical.com/first-patient-dosed-with-gene-therapy-in-phase-1-2-study-of-actus-101-in-patients-with-pompe-disease/ Thu, 28 May 2020 12:45:10 +0000 hourly 1 https://wordpress.org/?v=6.2